ConductScience.org, home

Paper40385486

Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease.

AlRasheed HA and 17 others. Front Pharmacol, 2025. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease. Papers, record 40385486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40385486

Download JSON
Disease
Parkinson disease333 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease.
PubMed
Journal
Front Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
2.92, provisional
iCite
Revised in PubMed
2025-05-20
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1AlRasheed HAHayam Ali
2Bahaa MMMostafa M
3Elmasry TAThanaa A
4Elberri EIEman I
5Kotkata FAFedaa A
6El Sabaa RMRamy M
7Elmorsi YMYasmine M
8Kamel MMMostafa M
9Negm WAWalaa A
10Hamouda AOAmir O
11Aldossary KMKhlood Mohammad
12Salahuddin MMMuhammed M
13Yasser MMohamed
14Eldesouqui MMamdouh
15Hamouda MAManal A
16Eltantawy NNashwa
17Elawady MEMirna E
18Abdallah MSMahmoud S

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05781711Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's DiseaseDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References75

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134396446Metformin inhibits cholesterol‑induced adhesion molecule expression via activating the AMPK signaling pathway in vascular smooth muscle cells.Mol Med Rep2021https://conductscience.org/library/papers/34396446PubMed
239225830Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39225830PubMed
335982135Tanshinone IIA reduces AQP4 expression and astrocyte swelling after OGD/R by inhibiting the HMGB1/RAGE/NF-κB/IL-6 pro-inflammatory axis.Sci Rep2022https://conductscience.org/library/papers/35982135PubMed
436757031Homocysteine, Vitamin B12 and Folate Level: Possible Risk Factors in the Progression of Chronic Heart and Kidney Disorders.Curr Cardiol Rev2023https://conductscience.org/library/papers/36757031PubMed
530310233Drug repurposing: progress, challenges and recommendations.Nat Rev Drug Discov2019https://conductscience.org/library/papers/30310233PubMed
628283884Resveratrol and Brain Mitochondria: a Review.Mol Neurobiol2018https://conductscience.org/library/papers/28283884PubMed
729288112The genetics of Parkinson disease.Ageing Res Rev2018https://conductscience.org/library/papers/29288112PubMed
839177895Blunted Melatonin Circadian Rhythm in Parkinson's Disease: Express Bewilderment.Neurotox Res2024https://conductscience.org/library/papers/39177895PubMed
932528295Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease.Front Pharmacol2020https://conductscience.org/library/papers/32528295PubMed
1021080186Pharmacokinetics of levodopa.J Neurol2010https://conductscience.org/library/papers/21080186PubMed
1127548849Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.Mov Disord2016https://conductscience.org/library/papers/27548849PubMed
1232813147Genetics of Parkinson's disease.Acta Neurol Belg2020https://conductscience.org/library/papers/32813147PubMed
1325637461Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity.Acta Neuropathol Commun2015https://conductscience.org/library/papers/25637461PubMed
1437667938
A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin.
Eur Rev Med Pharmacol Sci2023https://conductscience.org/library/papers/37667938PubMed
1531620963
Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis.
Daru2019https://conductscience.org/library/papers/31620963PubMed
1639156113The relation between Parkinson's disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis.Front Pharmacol2024https://conductscience.org/library/papers/39156113PubMed
1724269733The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.Neurobiol Dis2014https://conductscience.org/library/papers/24269733PubMed
1833431024A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions.J Cheminform2020https://conductscience.org/library/papers/33431024PubMed
1930519161Divergent Effects of Metformin on an Inflammatory Model of Parkinson's Disease.Front Cell Neurosci2018https://conductscience.org/library/papers/30519161PubMed
2024625392Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.Am J Pathol2014https://conductscience.org/library/papers/24625392PubMed

See all 75 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42872064HMGB1 functional plasticity in neurodegenerative diseases and its translational implications.Front Immunol2026https://conductscience.org/library/papers/42872064PubMed
42515753Context-Dependent Modulation of Ferroptosis by Metformin: Mechanisms, Therapeutic Implications and Open Questions.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515753PubMed
42039690Immunomodulatory and Anti-Inflammatory Effects of Ketotifen Versus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Pilot Study.Drug Des Devel Ther2026https://conductscience.org/library/papers/42039690PubMed
41898423Repurposing Antidiabetic Medications for Parkinson's Disease: Focus on Biomarker Strategies for Disease Modification.Int J Mol Sci2026https://conductscience.org/library/papers/41898423PubMed
41756254LKB1-AMPK Signaling Pathway in Cardiovascular and Other Diseases.MedComm (2020)2026https://conductscience.org/library/papers/41756254PubMed
41601525Interplay of oxidative stress and Inflammasome activation and clinical indices in Parkinson's disease: insights from serum SIRT1, Nrf2, and NLRP3 levels and PDQ-39-a cross-sectional study.Front Neurosci2025https://conductscience.org/library/papers/41601525PubMed
41130438Can maternal metformin protect the developing fetal brain?Am J Obstet Gynecol2026https://conductscience.org/library/papers/41130438PubMed
40649053Demographic and Clinical Characteristics of Hospitalized Patients with Type 2 Diabetes Mellitus and Comorbid Parkinson's Disease in Spain: A Nationwide Observational Study (2017-2023).J Clin Med2025https://conductscience.org/library/papers/40649053PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BDNF627PubTator's text mininghttps://conductscience.org/library/genes/627NCBI Gene
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146NCBI Gene
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622NCBI Gene
TLR47099PubTator's text mininghttps://conductscience.org/library/genes/7099NCBI Gene

Download CSV of genes

Drugs3

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
LEVODOPACHEMBL1009Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1009ChEMBL
CARBIDOPACHEMBL1200748Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1200748ChEMBL
METFORMINCHEMBL1431Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1431ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40385486

GET https://conductscience.org/api/papers/v1/40385486/references?page=2